CICERO, Ill., July 18, 2017 -- Broadwind Energy, Inc. (NASDAQ:BWEN) will announce second quarter 2017 results on Tuesday, August 1 before market open. An investor conference call will follow at 10 a.m. Central time. For real-time internet access to the conference call, visit investors.bwen.com/investors/events-and-presentations. An archived replay of the conference call will be available on the Company's website shortly after the call concludes.
About Broadwind Energy, Inc.
Broadwind Energy (NASDAQ:BWEN) is a precision manufacturer of structures, equipment and components for clean tech and other specialized applications. With facilities throughout the U.S., Broadwind Energy's talented team is committed to helping customers maximize performance of their investments—quicker, easier and smarter. Find out more at www.bwen.com
BWEN INVESTOR CONTACT: Joni Konstantelos, 708.780.4819 [email protected]


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 



